The role of the pharmacist in improving medication beliefs and adherence in cancer patients

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Nevzat BirandBilgen Başgut

Abstract

Multiple factors have been reported to affect adherence to medication, including beliefs about medicines, while specifically tailored pharmaceutical care services for patients may improve adherence. The aim was to assess the impact of counselling by an oncology pharmacist on patients' medication adherence and beliefs. An interventional prospective study was performed in the oncology department at a tertiary hospital in Northern Cyprus from November 2017 to April 2018. The Beliefs about Medicines Questionnaire was used to evaluate the balance between beliefs about necessity and concerns and medication beliefs before and after an educational intervention. The Morisky Green Levine Test 2018 was used to evaluate adherence. In total, 81 patients (65.4% females; mean age: 59.1 ± 11.34 years; 34.6% hypertensive; 19.8% with diabetes) were analysed before and after receiving counselling from an oncology pharmacist. Pharmacist education significantly enhanced the mean patient necessity-concern balance scores by two-fold (MT0(baseline) = -3.1 ± 8.6; MT1(posteducation) =3.0 ± 7.3; p < 0.0001), with patients who received counselling for the first time experiencing the greatest benefit. Multivariate analysis showed that patients who had a ne...Continue Reading

References

Nov 21, 1998·Journal of General Internal Medicine·P E BogdenL M Koontz
Jul 28, 1999·JAMA : the Journal of the American Medical Association·L L LeapeD W Bates
Sep 10, 2002·Medical Care·M Robin DiMatteoThomas W Croghan
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeJerry Avorn
Sep 17, 2004·Journal of Advanced Nursing·Wantana Maneesriwongul, Jane K Dixon
Oct 4, 2005·Patient Education and Counseling·Elizabeth A GrunfeldSangeeta Mittal
Aug 3, 2006·The Annals of Pharmacotherapy·Sachin ShahShane Greene
Oct 5, 2007·Patient Education and Counseling·Ann-Charlotte MårdbyTove Jörgensen
Mar 14, 2008·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Alexandre ChanLita Chew
Apr 30, 2008·Cancer·Tomasz P SrokowskiSharon H Giordano
Nov 18, 2008·Personality and Individual Differences·Julie B SchnurGuy H Montgomery
Jun 16, 2009·Journal of Developmental and Behavioral Pediatrics : JDBP·Dennis Drotar
Apr 9, 2010·The New England Journal of Medicine·David M Cutler, Wendy Everett
Jan 5, 2011·Journal of Oncology Practice·Jolynn K SessionsLew Iacovelli
Jan 18, 2011·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Megan McKeeScott A Soefje
Jan 21, 2011·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Aimee Danette RuderFrederic Henry Kass
Mar 18, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·John M ValgusStephen A Bernard
May 3, 2011·Journal of Oncology Practice·John HohnekerPatricia S Brandt
May 25, 2011·Oncology·Ralph WinterhalderUNKNOWN SAEDA Investigators Group (Swiss prospective cohort group)
Dec 31, 2011·International Journal of Clinical Pharmacy·Haitham W TuffahaSuha Al Omar
Feb 3, 2012·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Debi BhattacharyaSteven Watson
Jun 2, 2012·Journal of Pain and Symptom Management·Hayley S Whitford, Ian N Olver
Jun 13, 2012·Breast Cancer Research and Treatment·Caitlin C MurphySally W Vernon
Nov 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M T E PutsS M H Alibhai
Jan 31, 2014·International Journal of Clinical Pharmacy·Fátima CaracuelNuria Muñoz
May 17, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Siu-Fun WongElvin Hernandez
Nov 7, 2014·Journal of Family Medicine and Primary Care·Raniah Majed JamousSa'ed Husni Zyoud
Aug 11, 2015·British Journal of Clinical Pharmacology·Marie BarilletBénédicte Clarisse
Nov 6, 2015·BioMed Research International·Wai Yin Lam, Paula Fresco
Oct 5, 2017·International Journal of Clinical Pharmacy·Haider Al-BaghdadiBilgen Başgut
Mar 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M T E PutsS M H Alibhai

❮ Previous
Next ❯

Citations

Jul 4, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Garrett CrothersAutumn D Zuckerman
Jan 12, 2021·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Allison B BlackmerJames A Feinstein
Mar 30, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Renata Rv CataldoSabrina Calil-Elias
Jun 25, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Huijie QiQunyi Li

❮ Previous
Next ❯

Software Mentioned

Statistical Package for Social Sciences ( SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved